Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Melanoma 15Carcinoma, Non-Small-Cell Lung 6Neoplasms 4Uveal Melanoma 3Sarcoma 3Prostatic Neoplasms 3Neoplasm Metastasis 3Pancreatic Neoplasms 2Lung Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous-Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Diseases 1Osteosarcoma 1Neoplastic Cells, Circulating 1Neoplasms, Unknown Primary 1Neoplasms by Site 1Nasopharyngeal Carcinoma 1Metastatic Microsatellite Stable Colorectal Cancer 1Kidney Neoplasms 1Hypoxia 1Histiocytoma, Malignant Fibrous 1Head and Neck Neoplasms 1

Interventions

Methotrexate 5Drug Therapy 5apatinib 4Neoadjuvant Therapy 4Doxorubicin 3camrelizumab 2Ifosfamide 2Cisplatin 2trilaciclib 1spartalizumab 1palbociclib 1isophosphamide mustard 1irinotecan sucrosofate 1glucarpidase 1endostar protein 1Zoledronic Acid 1Vinorelbine 1Triptorelin Pamoate 1Trabectedin 1Therapeutics 1Thalidomide 1TQ-B3525 1Psychiatric Rehabilitation 1Nivolumab 1Neuropsychological Tests 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Microbiota 1Metabolome 1Magnetic Resonance Spectroscopy 1Lithium Carbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Osteosarcoma × Ipilimumab × Clear all
NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Assaf-Harofeh Medical Center

Phase 2 Unknown
60 enrolled
GastrointestinalSarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡